Methotrexate and Clonixin: Interaction Details

Brand names
Methotrexate
RheumatrexTrexallOtrexup +4 more
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Methotrexate

Brand names
  • Rheumatrex
  • Trexall
  • Otrexup
  • Rasuvo
  • Xatmep
  • Reditrex
  • Jylamvo

Clonixin

We don't have a drug information page for Clonixin yet. Have a question about Clonixin? Ask a pharmacist, free →

What Happens When You Take Methotrexate With Clonixin

What can happen when they are taken together (rated Major)

Increased methotrexate exposure, an increased risk of methotrexate-related severe adverse reactions, reduced active formation and possibly reduced methotrexate

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Giving together with methotrexate can raise methotrexate exposure, and that in turn may heighten the risk of severe methotrexate adverse reactions. In certain cases, the combination may also lead to reduced formation of active metabolites, which could lessen methotrexate's clinical effectiveness.1

As a general rule, NSAIDs should not be given before or at the same time as high-dose methotrexate (that is, the doses used in cancer therapy), because this can increase and prolong methotrexate exposure and raise the likelihood of methotrexate toxicities. and hematological toxicities, some of them severe and some fatal, have been reported when NSAIDs were coadministered with methotrexate (usually at high doses).

Many patients have tolerated low-dose methotrexate (that is, the 7.5 to 15 mg/week doses used for arthritis) given with NSAIDs well, but caution is still recommended. The combination of NSAIDs with higher methotrexate doses, such as those used for psoriasis, has not been fully evaluated.2 When the combination cannot be avoided, patients should be monitored closely for methotrexate adverse reactions.1

The Methotrexate and Clonixin Interaction, Explained

Clonixin is a pain reliever in the family (like ibuprofen). When it's taken with methotrexate, it can cause more methotrexate to stay in your body for longer, because the kidneys clear it more slowly. That can raise the chance of serious side effects, such as stomach and gut problems or low blood cell counts.

The risk is highest with the large methotrexate doses used for cancer. Low weekly doses for arthritis are often tolerated well, but caution is still wise. Please don't stop or change anything on your own. Talk with your pharmacist or doctor, who can tailor your doses and may monitor you more closely.

Mechanism: (including clonixin) can raise methotrexate exposure via reduced (decreased renal prostaglandin-mediated perfusion and tubular secretion competition), reduced , and protein binding displacement. Active formation may subsequently fall, possibly lowering .

  • Direction: increased MTX and prolonged exposure; neither agent is activated by this pathway in a way that reverses direction.
  • Severity/evidence: major, established, delayed onset. Severe and sometimes fatal and hematologic toxicity reported, mostly with high-dose MTX.
  • Management: avoid NSAIDs before or with high-dose MTX. With low-dose MTX (7.5 to 15 mg/week) often tolerated, but use caution. Psoriasis-range doses are not well studied. If unavoidable, monitor closely for MTX toxicity (CBC, renal function, GI effects) and individualize dosing.

See the 16 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Methotrexate and Clonixin Interact

The likely mechanism

Reduced methotrexate ; reduced of methotrexate; protein binding displacement

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Methotrexate and Clonixin Interaction

Your care team can manage this by choosing the safest approach for your dose and situation.

  • With high-dose methotrexate (cancer treatment), clonixin is generally avoided before or during treatment.
  • With low-dose weekly methotrexate (such as for arthritis), both are sometimes used together, with caution.
  • If both are needed, your methotrexate dose may need to be adjusted and individualized, and your team may monitor you more closely for side effects.

Keep taking your medicines as prescribed. Tell your pharmacist or prescriber about any you use, and report mouth sores, unusual bruising or bleeding, fever, or stomach pain promptly.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Methotrexate or Clonixin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

11 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Effect of aspirin and sulindac on methotrexate clearance

    The of low dose methotrexate were assessed in 12 patients with rheumatoid arthritis, both with and without chronic dosing of aspirin or sulindac. All patients had received methotrexate for at least 1 year and had been on a stable dose for at least 2 months before the study.

    A 3-way crossover design was used, in which patients received aspirin 45 to 50 mg/kg/day divided into 3 daily doses for 16 days, sulindac 200 mg every 12 hours for 16 days, or no . On day 14, methotrexate 10 mg/m(2) was given as an IV bolus and were measured.

    Methotrexate did not differ among the 3 treatments. However, the of the active 7-OH-methotrexate was increased, indicating that the body was exposed to the metabolite for a longer period with sulindac and to a greater extent with aspirin.

    The role of this metabolite in rheumatoid arthritis treatment is not fully understood, but it is thought to have some cytotoxic activity and to be capable of causing damage. Until the significance of the activity of 7-OH-methotrexate and the effect of prolonged exposure to it are established, these nonsteroidal antiinflammatory agents, especially aspirin, should be used with caution in combination with methotrexate.3

  2. Report 2 · Study title

    Aspirin alters methotrexate disposition in rheumatoid arthritis patients

    In 15 patients with rheumatoid arthritis, oral aspirin (3900 mg/day) and low-dose IV methotrexate (10 mg) were associated with a higher unbound fraction of methotrexate and lower systemic and of methotrexate. Single-dose disposition studies were carried out before and after 1 week of aspirin therapy. No hematologic, renal, or toxicity was observed.4

  3. Report 3 · Study title

    Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis

    No effect of naproxen on the disposition of low-dose methotrexate was demonstrated in 12 patients with rheumatoid arthritis and normal function. Patients received oral or IV methotrexate 15 mg, alone or with naproxen 1000 mg daily.

    Naproxen did not produce statistically significant changes in the systemic , renal clearance, or protein binding of methotrexate. Methotrexate toxicity was not evident with or without naproxen.5

  4. Report 4 · Study title

    Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis

    No interaction was observed between low-dose methotrexate and either ibuprofen 800 mg 3 times daily or flurbiprofen 100 mg 3 times daily in 6 patients with rheumatoid arthritis, as assessed by , , time to peak , or . Assessments were done 48 hours before dosing and after 6 days of NSAID, with the methotrexate dose kept fixed.

    Results were similar after oral and IM methotrexate. All patients had normal function and none were taking .6 In patients stabilized on methotrexate for at least 3 months, 6 days of treatment with flurbiprofen 3 mg/kg/day, ketoprofen 3 mg/day, or piroxicam 20 mg/day produced no change in methotrexate (oral or renal), unbound fraction, or amount excreted unchanged.7

  5. Report 5 · Study title

    Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis

    The interaction between methotrexate and several (tolmetin, indomethacin, naproxen, and aspirin) was examined in 7 children with chronic arthritis. In all 7 patients, the mean of methotrexate was significantly prolonged when an was coadministered, whereas methotrexate , , and volume of distribution did not change significantly.

    Although changes in methotrexate clearance were not statistically significant, they varied widely. In 6 of 7 patients, AUC rose by 19% to 140%, suggesting that some children may have clinically significant increases in methotrexate levels with NSAID use.8

  6. Report 6 · Study title

    Diclofenac: a reappraisal

    of diclofenac and methotrexate has led to severe, sometimes fatal, toxicity in patients with rheumatoid arthritis or malignant neoplasms. Diclofenac and other seem to inhibit the of methotrexate, resulting in toxic serum methotrexate concentrations. administration should be avoided.9

  7. Report 7 · Study title

    Serious methotrexate toxicity caused by interaction with ibuprofen (letter)

    Severe toxicity was reported with high-dose methotrexate (12 g) and ibuprofen 400 mg every 4 hours in an 18-year-old man with osteogenic sarcoma. Twenty hours after the start of a 6 hour methotrexate infusion, his serum creatinine was 2.3 mg/dL and his methotrexate level was 1.8 x 10(-4) M.

    Sixty-eight hours after the infusion, serum creatinine was 3.5 mg/dL. Immediate, intensive rescue with folinic acid and thymidine brought the serum creatinine to 1.6 mg/dL at hour 284.10

  8. Report 8 · Study title

    Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen

    ketoprofen and high-dose methotrexate 800 to 8300 mg/m(2) has produced severe methotrexate toxicity and fatality. Ketoprofen was given simultaneously in 4 of 118 cycles of high-dose methotrexate in 36 patients, and all 4 cycles were associated with severe methotrexate toxicity, with fatality in 3 cases.

    A mechanism was speculated to underlie the interaction, possibly involving ketoprofen of renal prostaglandin synthesis, leading to reduced renal perfusion and inhibited methotrexate . Competitive renal secretion was also suggested. In another patient in this series, diclofenac was associated with severe methotrexate toxicity, and other may also be involved in this reaction.11

  9. Report 9 · Study title

    Thrombocytopenia after a single test dose of methotrexate

    A 36 year-old woman with juvenile rheumatoid arthritis had sarcoidosis with worsening cutaneous lesions. Her arthritis was treated with ibuprofen 600 mg three times daily.

    Laboratory studies showed no evidence of insufficiency or abnormal serum albumin, and her count was 195,000/mm(3). One week after her first dose of oral methotrexate 7.5 mg, she noticed prolonged bleeding after a superficial laceration and multiple petechiae.

    Four days later, her platelet count was 25,000/mm(3). Ibuprofen and methotrexate were both discontinued, and nine days later her platelet count was 185,000/mm(3).15

  10. Report 10 · Study title

    Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen

    Several case reports have shown that , including ketoprofen, given with methotrexate can raise methotrexate levels and cause toxicity.11121314

  11. Report 11 · Study title

    Methotrexate and nonsteroidal antiinflammatory drug interactions

    A 74-year-old woman had been treated for 3 years with methotrexate 2.5 mg three times a week for rheumatoid arthritis. Flurbiprofen 100 mg per day was then added.

    One to two weeks later, she was hospitalized for one week with hematemesis, diarrhea with melena, nausea, and weakness. Other medications at admission included folic acid, digoxin, gemfibrozil, iron supplements, and dipyridamole.

    Acute bleeding was found. She was also diagnosed with anemia, , and secondary to methotrexate therapy.16

Methotrexate and Clonixin: Common Questions

How serious is the Methotrexate and Clonixin interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Methotrexate and Clonixin interaction managed?

Your care team can manage this by choosing the safest approach for your dose and situation. With high-dose methotrexate (cancer treatment), clonixin is generally avoided before or during treatment. With low-dose weekly methotrexate (such as for arthritis), both are sometimes used together, with caution. If both are needed, your methotrexate dose may need to be adjusted and individualized, and your… Management is individual — always follow your own care team's guidance.

Who is at higher risk from the Methotrexate and Clonixin interaction?

The interaction record names this group as more likely to be affected:

  • People taking higher doses

If this describes you, tell your pharmacist or prescriber.

How quickly could this interaction happen?

The documented onset is "delayed". Effects tend to build up gradually over days to weeks.

How strong is the evidence for this interaction?

The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.

Ask About the Methotrexate and Clonixin Interaction

Ask in your own words about taking Methotrexate and Clonixin together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (16)

  1. Product Information: JYLAMVO oral solution, methotrexate oral solution. Shorla Oncology Inc (per FDA), Cambridge, MA, 2024. DailyMed
  2. Product Information: OTREXUP(TM) subcutaneous injection solution, methotrexate subcutaneous injection solution. Antares Pharma, Inc. (per manufacturer), Ewing, NJ, 2013. DailyMed
  3. Furst DE, Herman RA, Koehnke R, et al: Effect of aspirin and sulindac on methotrexate clearance. J Pharm Sci 1990; 79:782-786. PubMed
  4. Stewart CF, Fleming RA, Germain BF, et al: Aspirin alters methotrexate disposition in rheumatoid arthritis patients. Arthritis Rheum 1991; 34:1514-1520. DOI
  5. Stewart CF, Fleming RA, Arkin CR, et al: Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis. Clin Pharmacol Ther 1990; 47:540-546. PubMed
  6. Skeith KJ, Russell AS, Jamali F, et al: Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis. J Rheumatol 1990; 17:1008-1010.
  7. Tracy TS, Worster T, Bradley JD, et al: Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis. Br J Clin Pharmacol 1994; 37:453-456. DOI
  8. Dupuis LL, Shore A, Silverman ED, et al: Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis. J Rheumatol 1990; 17:1469-1473.
  9. Todd PA & Sorkin EM: Diclofenac: a reappraisal. Drugs 1988; 35:244-285.
  10. Cassano WF: Serious methotrexate toxicity caused by interaction with ibuprofen (letter). Am J Pediatr Hematol Oncol 1989; 11:481-482.
  11. Thyss A, Milano G, Kubar J, et al: Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen. Lancet 1986; 1:256-258. PubMed
  12. Daly H, Boyle J, Roberts C, et al: Interaction between methotrexate and non-steroidal anti-inflammatory drugs. Lancet 1986; 1:559. DOI
  13. Maiche AG: Acute renal failure due to concomitant action of methotrexate and indomethacin (letter). Lancet 1986; 1:1390. PubMed
  14. Singh RR, Malaviya AN, Pandey JN, et al: Fatal interaction between methotrexate and naproxen (letter). Lancet 1986; 1:1390. DOI
  15. Jih DM & Werth VP: Thrombocytopenia after a single test dose of methotrexate. J Am Acad Dermatol 1998; 39:349-351. PubMed
  16. Frenia ML & Long KS: Methotrexate and nonsteroidal antiinflammatory drug interactions. Ann Pharmacother 1992; 26:234-237. DOI
Was this write-up helpful?

Other Serious Interactions of Methotrexate and Clonixin

Also serious with Methotrexate

Also serious with Clonixin

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Methotrexate

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data. This interaction.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks. This interaction.
  • UnspecifiedThe timing of this interaction is not well characterized.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.